Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
The coronavirus disease 2019 (COVID-19) pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 22 million individuals and resulted in over 780,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development o...
Main Authors: | Hsin-I Shih, Chi-Jung Wu, Yi-Fang Tu, Chia-Yu Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Biomedical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2319417020300858 |
Similar Items
-
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
by: Ebenezer Tumban
Published: (2020-12-01) -
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
by: Giovanni Salvatori, et al.
Published: (2020-06-01) -
Neglected SARS-CoV-2 variants and potential concerns for molecular diagnostics: a framework for nucleic acid amplification test target site quality assurance
by: Gregory R. McCracken, et al.
Published: (2023-12-01) -
Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2
by: Chotiwat Seephetdee, et al.
Published: (2021-05-01) -
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
by: Fatima Amanat, et al.
Published: (2021-04-01)